Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Share buyback programme

24 Sep 2024 07:00

RNS Number : 3311F
Johnson Matthey PLC
24 September 2024
 

24th September 2024

 

Johnson Matthey Plc

Share buyback programme

 

On 3rd July 2024, Johnson Matthey Plc ("JM" or the "Company") announced its intention to conduct a share buyback programme to purchase ordinary shares of 110 49/53 pence each in the Company ("Ordinary Shares") for up to a maximum consideration of £250m (the "Buyback").

 

The first tranche of this Buyback (up to a maximum consideration of £125m) commenced on 3rd July 2024 and completed on 23rd September 2024, in accordance with its terms.

 

The Company announces that the second tranche of the Buyback of up to £125m will commence today and end no later than 24th January 2025. Purchases of the Company's ordinary shares will commence immediately.

 

The Company has entered into an irrevocable, non-discretionary agreement with Citigroup Global Markets Limited ("Citi") to manage the Programme, pursuant to which Citi will purchase Johnson Matthey Ordinary Shares (acting as principal) for subsequent repurchase by the Company. Citi will make trading decisions under the Programme independently of JM. Purchases may continue during any closed period to which the Company is subject.

 

The sole purpose of the Programme is to reduce the share capital of the Company. All shares repurchased under the Programme will be cancelled.

 

The maximum number of shares that may be repurchased under the Buyback is 18,393,997 shares, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2024 Annual General Meeting (the "2024 AGM") and any subsequent authority.

Any purchase of Johnson Matthey ordinary shares in relation to this announcement will be effected within certain pre-set parameters and in accordance with Johnson Matthey's general authority to repurchase ordinary shares granted by its shareholders at the 2024 AGM, Chapter 12 of the Financial Conduct Authority's UK Listing Rules, the Market Abuse Regulation (EU) 596/2014 (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019); and the Commission Delegated Regulation (EU) No 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019). No repurchases will be made in respect of the Company's American Depositary Receipts.

 

 

ENDS

 

Enquiries: 

 

Martin Dunwoodie

Victoria Barlow

Director of Investor Relations and Treasury

Deputy Company Secretary

+44 20 7269 8241

+44 20 7269 8431

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEUESDELSEFU
Date   Source Headline
29th Sep 20204:52 pmRNSDirector/PDMR Shareholding
21st Sep 20204:08 pmRNSDirector/PDMR Shareholding
18th Sep 20204:21 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSJohnson Matthey: Hydrogen Seminar
21st Aug 20209:05 amRNSDirector/PDMR Shareholding
11th Aug 202010:12 amRNSDoug Webb - New Directorship
6th Aug 20204:19 pmRNSDirector/PDMR Shareholding
6th Aug 20204:11 pmRNSDirector/PDMR Shareholding
5th Aug 20204:25 pmRNSDirector/PDMR Shareholding
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 20204:04 pmRNSDirector/PDMR Shareholding
30th Jul 20202:45 pmRNSDirector Declaration
23rd Jul 20203:25 pmRNSResult of AGM
23rd Jul 20207:00 amRNSJohnson Matthey Q1 AGM trading update
17th Jul 20201:31 pmRNSDirector/PDMR Shareholding
14th Jul 202012:18 pmRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSAnna Manz, CFO, to leave JM and join LSEG
23rd Jun 20207:00 amRNSAnnual Financial Report
19th Jun 20203:14 pmRNSDirector/PDMR Shareholding
16th Jun 20205:13 pmRNSDirector/PDMR Shareholding
16th Jun 20209:00 amRNSCompany Secretary Change
11th Jun 20207:00 amRNSPreliminary results for year ended 31st March 2020
4th Jun 20204:35 pmRNSDirector/PDMR Shareholding
21st May 20204:08 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSJohnson Matthey revised date for full year results
28th Apr 20203:45 pmRNSRights attaching to ordinary shares
22nd Apr 20207:00 amRNSJM and COVID-19: supporting our stakeholders
16th Apr 20204:56 pmRNSDirector/PDMR Shareholding
2nd Apr 202010:31 amRNSJane Griffiths - New Directorship
1st Apr 20207:00 amRNSCompany Secretary Change
30th Mar 20207:00 amRNSJohnson Matthey pre-close trading statement
19th Mar 20203:11 pmRNSDirector/PDMR Shareholding
25th Feb 202011:04 amRNSDirector/PDMR Shareholding
20th Feb 20203:35 pmRNSDirector/PDMR Shareholding
6th Feb 20205:33 pmRNSDirector/PDMR Shareholding
6th Feb 20203:52 pmRNSDirector/PDMR Shareholding
6th Feb 20203:41 pmRNSDirector/PDMR Shareholding
6th Feb 20203:29 pmRNSDirector/PDMR Shareholding
4th Feb 20207:30 amRNSJohn O'Higgins - New Directorship
17th Jan 202010:09 amRNSDirector/PDMR Shareholding
19th Dec 20194:31 pmRNSDirector/PDMR Shareholding
26th Nov 20195:06 pmRNSHolding(s) in Company
26th Nov 20195:01 pmRNSDirector/PDMR Shareholding
26th Nov 20194:53 pmRNSDirector/PDMR Shareholding
26th Nov 20194:41 pmRNSDirector/PDMR Shareholding
25th Nov 201911:56 amRNSDirector/PDMR Shareholding
25th Nov 201910:18 amRNSDirector/PDMR Shareholding
21st Nov 20192:24 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSHalf-year Report
17th Oct 20193:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.